Masahiro Hiasa
- Hematology top 2%
- Multiple Myeloma Research and Treatments 21
- Oncology top 5%
- Bone health and treatments 13
- Peptidase Inhibition and Analysis 7
-
- Bone Metabolism and Diseases 8
- Histone Deacetylase Inhibitors Research 6
-
- Cancer Mechanisms and Therapy 8
-
- Pain Mechanisms and Treatments 7
-
- Craniofacial Disorders and Treatments 5
- Co-authors
- Toshiyuki YonedaTatsuo OkuiMasahiro AbeToshio MatsumotoKyoko TakeuchiAsuka OdaShuji OzakiHiroe Amou
- Partner nations
- JapanUnited StatesSaudi Arabia
In The Last Decade
Masahiro Hiasa
55 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 101
- Hematology 399
- Oncology 542
- Orthopedics and Sports Medicine 95
- Molecular Biology 597
- Cancer Research 129
Countries citing papers authored by Masahiro Hiasa
This map shows the geographic impact of Masahiro Hiasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Hiasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Hiasa more than expected).
Fields of papers citing papers by Masahiro Hiasa
This network shows the impact of papers produced by Masahiro Hiasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Hiasa. The network helps show where Masahiro Hiasa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masahiro Hiasa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 6 | |
| 11 | 2022 | 1 | |
| 12 | 2019 | 6 | |
| 13 | 2018 | 31 | |
| 14 | 2017 | 69 | |
| 15 | Bone pain induced by multiple myeloma is reduced by targeting V-ATPase and ASIC3 | 2017 | 4 |
| 16 | 2016 | 158 | |
| 17 | 2011 | 4 | |
| 18 | 2011 | 22 | |
| 19 | 2010 | 108 | |
| 20 | 2008 | 25 |
About Masahiro Hiasa
Masahiro Hiasa is a scholar working on Hematology, Orthodontics and Complementary and Manual Therapy, having authored 57 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (21 papers), Bone health and treatments (13 papers), Cancer Mechanisms and Therapy (8 papers), Bone Metabolism and Diseases (8 papers), Peptidase Inhibition and Analysis (7 papers), Pain Mechanisms and Treatments (7 papers), Histone Deacetylase Inhibitors Research (6 papers) and Craniofacial Disorders and Treatments (5 papers). The work is most often cited by research in Hematology (399 citations), Oncology (542 citations) and Orthopedics and Sports Medicine (95 citations). Masahiro Hiasa has collaborated with scholars based in Japan, United States and Saudi Arabia. Frequent co-authors include Toshiyuki Yoneda, Tatsuo Okui, Masahiro Abe, Toshio Matsumoto, Kyoko Takeuchi, Asuka Oda, Shuji Ozaki, Hiroe Amou, Fletcher A. White and Takeshi Harada. Their work appears in journals such as Nature Communications, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.